Lifeforce
Closed-loop model combining diagnostics, clinician, and prescription therapeutics under one membership
NOT CLEARED
No FDA clearance, registration, or CE marking found.
Key facts at a glance.
- Founded
- 2021
- Headquarters
- Carlsbad, CA, USA
- Price range
- $349–$349
- App ratings
- iOS 4.6 · Android 4
The real price over three years.
Total cost of ownership · 3yr
| Hardwareone-time | $349 |
| 3-year total | $349 |
What the device does.
- + 40+ biomarker diagnostic panel incl. hormones, metabolic, inflammation
- + Physician and health-coach consultation included
- + Prescription optimization pathway (HRT, GLP-1, peptides)
- + Quarterly retesting cadence
- + Co-founded with Tony Robbins and Peter Diamandis brand halo
The trade-offs.
- + **Closed-loop diagnostic + clinician + prescription model** — only major DTC platform integrating HRT, GLP-1, and peptide pathways
- + 40+ biomarker panel with quarterly retesting cadence — designed for protocol iteration
- + Physician + health-coach consultations included in membership (not upsold separately)
- + Tony Robbins / Peter Diamandis brand halo provides credibility signal in concierge wellness market
- + 2021-founded with rapid execution maturity — clinician network is operational at scale
- − **$349/mo membership is the most expensive serious DTC platform** — substantial commitment vs $499/yr alternatives
- − 40+ biomarker count is smaller than Function Health (110+) or Mito Health (100+)
- − Aggressive supplement and prescription upsells — closed-loop economics depend on this
- − Quarterly retesting cadence is too frequent for many use cases — paying for frequency you may not need
- − Brand halo from celebrity co-founders is marketing, not regulatory or clinical certification
Affluent 35+ adults seeking closed-loop longevity care including HRT and peptides
The long read.
§ Hands-on instrument testing pending. Based on published specifications and third-party data.
Overview
Lifeforce is the closed-loop concierge longevity specialist in the consumer DTC blood-test category — founded 2021 in Carlsbad CA, co-founded with Tony Robbins and Peter Diamandis brand halo. The structural differentiator is the end-to-end diagnostic + clinician + prescription model: membership includes 40+ biomarker quarterly testing, physician consultations, health-coach support, and prescription optimization pathways for HRT, GLP-1, and peptide therapeutics.
This is the only major DTC blood-test platform with integrated prescription therapeutics. Function Health gives you data; Superpower gives you AI recommendations + supplement upsells; Lifeforce gives you actual prescription pathways under physician oversight. For affluent 35+ adults seeking concierge longevity care including hormone optimization, Lifeforce occupies a category position no competitor matches.
The structural editorial caveat: $349/month membership is the most expensive serious DTC platform in the category. The closed-loop economics depend on supplement, prescription, and consultation upsells — buyers should expect aggressive upsell pressure. The price premium is justified for users who would otherwise need to assemble the same care stack across multiple separate vendors; for users running simpler protocols, the cost is hard to justify.
What We Measured
Note: This review is based on Lifeforce’s published membership specifications, clinician-network positioning, prescription-pathway documentation, and aggregated user reports. Hands-on testing of the membership experience (consultation depth, prescription pathway, app usability) is pending.
The closed-loop model
This is the structural differentiator. Lifeforce membership integrates:
- 40+ biomarker diagnostic panel quarterly (4× per year)
- Physician consultation included in membership
- Health-coach support included in membership
- Prescription optimization pathway for HRT, GLP-1, peptides, other relevant therapeutics
- Supplement marketplace with member discounts
Compare:
- Function Health: data + portal, no clinician, no prescriptions
- Superpower: data + AI chat + supplement marketplace, no prescriptions
- InsideTracker: data + recommendations, no clinician, no prescriptions
- Lifeforce: data + clinician + prescriptions + supplements (closed loop)
For buyers who want a single membership covering the full diagnostic-to-treatment pathway, Lifeforce is structurally the only consumer-tier option. For buyers comfortable assembling separate vendors (Function Health for data + separate concierge clinic for prescriptions), the unbundled approach can be cheaper.
The HRT / GLP-1 / peptide pathway
This is the central editorial value proposition. Lifeforce’s prescription pathway is operational at scale for:
- Hormone Replacement Therapy (testosterone, estradiol, progesterone) — for users with biomarker-validated deficiencies
- GLP-1 agonists (semaglutide, tirzepatide) — for weight-management indications
- Peptide therapeutics (where state regulations permit) — BPC-157, CJC-1295, other longevity-relevant peptides
The pathway requires biomarker validation, physician consultation, and ongoing monitoring under the membership umbrella. This structurally differs from “just go to a TRT clinic” because the diagnostic baseline and ongoing monitoring are integrated into the same membership.
For users seeking physician-supervised hormone optimization via DTC platform, Lifeforce is the leading consumer-tier choice. For users seeking specialty-clinic depth (e.g., Defy Medical for advanced HRT protocols), Lifeforce is a defensible starting point but specialty clinics may go deeper on niche protocols.
The 40+ biomarker panel
The Lifeforce panel covers 40+ biomarkers including hormones, metabolic, inflammation, lipids, vitamins. The biomarker count is smaller than Function Health (110+) or Mito Health (100+).
The trade-off: Lifeforce’s panel is focused on actionable hormone-optimization biomarkers, not maximum theoretical breadth. For users running HRT/GLP-1 protocols, the relevant biomarkers are well-covered. For users running comprehensive longevity-bloodwork sweeps, Function Health or Mito Health offer more breadth.
The aggressive-upsell pattern
Multiple consumer reports document aggressive supplement and prescription upsells throughout the membership experience. The closed-loop economics depend on conversions — supplement purchases, prescription refills, consultation upgrades.
The honest editorial framing: the upsell pressure is a feature of the business model, not a bug. Lifeforce’s $349/mo membership doesn’t pencil out without the conversion economics. Buyers should expect routine upsell pressure and weight whether they’re disciplined enough to filter recommendations to those that actually fit their protocol.
3-Year Cost of Ownership
| Use case | Annual cost | 3-year total |
|---|---|---|
| Lifeforce membership only | ~$349 × 12 = $4,188 | ~$12,564 |
| Membership + supplement stack ($150/mo avg) | ~$5,988 | ~$17,964 |
| Membership + HRT prescription pathway | ~$5,000–8,000 | ~$15,000–24,000 |
Compare: Function Health ($1,497 / 3 yr, data only), Superpower ($597 / 3 yr, AI + supplement marketplace), Mito Health ($2,040 / 3 yr).
Lifeforce is the most expensive DTC platform by a wide margin. The cost structure assumes substantial supplement / prescription conversion, which makes the realistic 3-year TCO meaningfully higher than the headline membership fee.
For buyers who would otherwise pay $200–400/mo for separate concierge-clinic access, the Lifeforce membership is competitive on a bundled-cost basis. For buyers comparing against Function Health’s $499/yr data-only model, Lifeforce is 8× more expensive.
Regulatory Status
Not FDA-Cleared. The diagnostic component runs through CLIA-certified lab partners. The prescription pathway operates under standard physician-licensure regulations (state-by-state). The supplement marketplace operates under standard supplement-industry regulation.
The closed-loop model requires more state-regulatory navigation than data-only platforms. Some prescription pathways are not available in all states; service availability varies.
When Lifeforce Makes Sense — And When It Doesn’t
Strong fit:
- You want integrated diagnostic + clinician + prescription pathway under a single membership
- You’re pursuing HRT / GLP-1 / peptide protocols and want physician-supervised access via DTC platform
- You’re affluent 35+ — the membership cost is manageable within your wellness budget
- You value bundled concierge-care economics vs assembling separate vendors
- You’re disciplined enough to filter aggressive supplement / prescription upsells
Weaker fit:
- You want data-only without clinician overhead — Function Health is structurally better at $499/yr
- You want maximum biomarker breadth — Function Health (110+) or Mito Health (100+) are structurally better
- You’re cost-sensitive — Lifeforce is the most expensive serious DTC platform
- You’re an experienced biohacker who finds clinician oversight unhelpful for established protocols
- You distrust celebrity-cofounder brand halos — Tony Robbins / Peter Diamandis positioning may signal “marketing markup”
Verdict: Recommended
Lifeforce earns a recommended verdict on the strength of its category-unique closed-loop model — only major DTC platform integrating diagnostics + clinician consultation + HRT/GLP-1/peptide prescription pathways under a single membership — backed by operational maturity (2021-founded with scaled clinician network) and affluent-target brand positioning.
For buyers seeking physician-supervised hormone optimization or weight-management therapeutics via DTC platform, Lifeforce is structurally the leading consumer-tier choice. The closed-loop economics justify the $349/mo premium for users who would otherwise pay $200–400/mo for separate concierge-clinic access plus diagnostic costs.
For buyers prioritizing data-only access, maximum biomarker breadth, or cost-sensitivity, Function Health, Mito Health, or InsideTracker are structurally better matches. Lifeforce is the concierge-longevity specialist with corresponding price-premium positioning — buyers should weight whether the closed-loop pathway matches their actual decision-driver before committing.
Changelog
- 2026-05-06: Initial review published based on Lifeforce’s published membership specifications, clinician-network positioning, prescription-pathway documentation, and aggregated user-report data.